These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8205528)

  • 41. The adoptive transfer of cultured T cells for patients with metastatic melanoma.
    Yang JC
    Clin Dermatol; 2013; 31(2):209-19. PubMed ID: 23438384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes.
    Topalian SL; Hom SS; Kawakami Y; Mancini M; Schwartzentruber DJ; Zakut R; Rosenberg SA
    J Immunother (1991); 1992 Oct; 12(3):203-6. PubMed ID: 1445813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes.
    Morel S; Ooms A; Van Pel A; Wölfel T; Brichard VG; van der Bruggen P; Van den Eynde BJ; Degiovanni G
    Int J Cancer; 1999 Dec; 83(6):755-9. PubMed ID: 10597191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor antigens recognized by T lymphocytes.
    Boon T; Cerottini JC; Van den Eynde B; van der Bruggen P; Van Pel A
    Annu Rev Immunol; 1994; 12():337-65. PubMed ID: 8011285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens.
    Prickett TD; Crystal JS; Cohen CJ; Pasetto A; Parkhurst MR; Gartner JJ; Yao X; Wang R; Gros A; Li YF; El-Gamil M; Trebska-McGowan K; Rosenberg SA; Robbins PF
    Cancer Immunol Res; 2016 Aug; 4(8):669-78. PubMed ID: 27312342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunosuppression in inflammatory melanoma: can it be resisted by adoptively transferred T cells?
    Auphan-Anezin N; Verdeil G; Grange M; Soudja SM; Wehbe M; Buferne M; Mas A; Schmitt-Verhulst AM
    Pigment Cell Melanoma Res; 2013 Mar; 26(2):167-75. PubMed ID: 23217139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
    Robbins PF; El-Gamil M; Li YF; Kawakami Y; Loftus D; Appella E; Rosenberg SA
    J Exp Med; 1996 Mar; 183(3):1185-92. PubMed ID: 8642260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.
    Skipper JC; Hendrickson RC; Gulden PH; Brichard V; Van Pel A; Chen Y; Shabanowitz J; Wolfel T; Slingluff CL; Boon T; Hunt DF; Engelhard VH
    J Exp Med; 1996 Feb; 183(2):527-34. PubMed ID: 8627164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
    Spranger S; Luke JJ; Bao R; Zha Y; Hernandez KM; Li Y; Gajewski AP; Andrade J; Gajewski TF
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7759-E7768. PubMed ID: 27837020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [New immunotherapy for patients with neoplasms using tumor antigens recognized by T lymphocytes].
    Kawakami Y
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2536-44. PubMed ID: 9922678
    [No Abstract]   [Full Text] [Related]  

  • 51. Induction of tumor-infiltrating lymphocytes in human malignant melanoma metastases by immunization to melanoma antigen vaccine.
    Oratz R; Cockerell C; Speyer JL; Harris M; Roses D; Bystryn JC
    J Biol Response Mod; 1989 Aug; 8(4):355-8. PubMed ID: 2754436
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neoantigen landscape dynamics during human melanoma-T cell interactions.
    Verdegaal EM; de Miranda NF; Visser M; Harryvan T; van Buuren MM; Andersen RS; Hadrup SR; van der Minne CE; Schotte R; Spits H; Haanen JB; Kapiteijn EH; Schumacher TN; van der Burg SH
    Nature; 2016 Aug; 536(7614):91-5. PubMed ID: 27350335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melanoma, vitiligo, and uveitis.
    Albert DM
    Ophthalmology; 2010 Mar; 117(3):643-4; author reply 644. PubMed ID: 20189042
    [No Abstract]   [Full Text] [Related]  

  • 54. A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients.
    Godet Y; Bonnin A; Guilloux Y; Vignard V; Schadendorf D; Dreno B; Jotereau F; Labarriere N
    Cancer Immunol Immunother; 2009 Feb; 58(2):271-80. PubMed ID: 18612636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma.
    Kalaora S; Wolf Y; Feferman T; Barnea E; Greenstein E; Reshef D; Tirosh I; Reuben A; Patkar S; Levy R; Quinkhardt J; Omokoko T; Qutob N; Golani O; Zhang J; Mao X; Song X; Bernatchez C; Haymaker C; Forget MA; Creasy C; Greenberg P; Carter BW; Cooper ZA; Rosenberg SA; Lotem M; Sahin U; Shakhar G; Ruppin E; Wargo JA; Friedman N; Admon A; Samuels Y
    Cancer Discov; 2018 Nov; 8(11):1366-1375. PubMed ID: 30209080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.
    Wolchok JD; Yuan J; Houghton AN; Gallardo HF; Rasalan TS; Wang J; Zhang Y; Ranganathan R; Chapman PB; Krown SE; Livingston PO; Heywood M; Riviere I; Panageas KS; Terzulli SL; Perales MA
    Mol Ther; 2007 Nov; 15(11):2044-50. PubMed ID: 17726460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunotherapeutic strategies: the melanoma example.
    Jorritsma A; Schumacher TN; Haanen JB
    Immunotherapy; 2009 Jul; 1(4):679-90. PubMed ID: 20635992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients.
    Housseau F; Lindsey KR; Oberholtzer SD; Gonzales MI; Boutin P; Moorthy AK; Shankara S; Roberts BL; Topalian SL
    J Immunol Methods; 2002 Aug; 266(1-2):87-103. PubMed ID: 12133625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.
    Strønen E; Toebes M; Kelderman S; van Buuren MM; Yang W; van Rooij N; Donia M; Böschen ML; Lund-Johansen F; Olweus J; Schumacher TN
    Science; 2016 Jun; 352(6291):1337-41. PubMed ID: 27198675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T-cell recognition of melanoma antigens and its therapeutic applications.
    Castelli C; Rivoltini L; Mazzocchi A; Parmiani G
    Int J Clin Lab Res; 1997; 27(2):103-10. PubMed ID: 9266280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.